𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Accelerated life regression modelling of dependent bivariate time-to-event data

✍ Scribed by Yun-Hee Choi; David E. Matthews


Publisher
John Wiley and Sons
Year
2005
Tongue
French
Weight
991 KB
Volume
33
Category
Article
ISSN
0319-5724

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Joint modelling of longitudinal and time
✍ Michael J. Sweeting; Simon G. Thompson πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 353 KB πŸ‘ 2 views

## Abstract Shared random effects joint models are becoming increasingly popular for investigating the relationship between longitudinal and time‐to‐event data. Although appealing, such complex models are computationally intensive, and quick, approximate methods may provide a reasonable alternative

An overview of techniques for linking hi
✍ Harald Binder; Christine Porzelius; Martin Schumacher πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 253 KB πŸ‘ 2 views

## Abstract Analysis of molecular data promises identification of biomarkers for improving prognostic models, thus potentially enabling better patient management. For identifying such biomarkers, risk prediction models can be employed that link high‐dimensional molecular covariate data to a clinica

An application of nonlinear mixed-effect
✍ L. Iavarone; R. Gomeni πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

A population pharmacokinetic (PK) analysis was performed on plasma concentrations of GW468816 observed in dogs after 10, 25, and 50 mg/kg/day repeated intravenous administration. A two-compartment model was fitted to the concentration-time data using the NONMEM program. Dose and time dependency of P

Non-parametric covariance methods for in
✍ Catherine M. Tangen; Gary G. Koch πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 3 views

The principal response criteria for many clinical trials involve time-to-event variables. Usual methods of analysis for this type of response criterion include product-limit estimators of cumulative survival for the treatment groups, (stratified) logrank tests to compare treatments, and proportional